PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
5.23%
Revenue growth above 1.5x ADI's 2.11%. David Dodd would confirm if the firm has a unique advantage driving sales higher.
5.71%
Gross profit growth above 1.5x ADI's 2.18%. David Dodd would confirm if the company's business model is superior in terms of production costs or pricing.
0.51%
EBIT growth similar to ADI's 0.47%. Walter Schloss might infer both firms share similar operational efficiencies.
6.95%
Operating income growth above 1.5x ADI's 0.47%. David Dodd would confirm if consistent cost or pricing advantages drive this outperformance.
3.85%
Net income growth above 1.5x ADI's 0.52%. David Dodd would check if a unique moat or cost structure secures superior bottom-line gains.
3.83%
EPS growth of 3.83% while ADI is zero. Bruce Berkowitz would see if minimal gains can accelerate over time.
3.89%
Diluted EPS growth of 3.89% while ADI is zero. Bruce Berkowitz would see if minimal gains can be scaled further for a bigger lead.
0.33%
Slight or no buybacks while ADI is reducing shares. John Neff might see a missed opportunity if the company’s stock is cheap.
0.32%
Diluted share count expanding well above ADI's 0.21%. Michael Burry would fear significant dilution to existing owners' stakes.
-0.01%
Both companies cut dividends. Martin Whitman would look for a common factor, such as cyclical downturn or liquidity constraints.
-12.94%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
-19.39%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
60.04%
10Y revenue/share CAGR at 75-90% of ADI's 73.37%. Bill Ackman would press for new markets or product lines to narrow the gap.
55.67%
5Y revenue/share CAGR at 75-90% of ADI's 70.71%. Bill Ackman would encourage strategies to match competitor’s pace.
20.69%
3Y revenue/share CAGR above 1.5x ADI's 2.59%. David Dodd would confirm if there's an emerging competitive moat driving recent gains.
353.80%
10Y OCF/share CAGR above 1.5x ADI's 60.01%. David Dodd would check if a superior product mix or cost edge drives this outperformance.
269.23%
5Y OCF/share CAGR above 1.5x ADI's 64.16%. David Dodd would confirm if the firm has better cost structures or brand premium boosting mid-term cash flow.
77.37%
3Y OCF/share CAGR above 1.5x ADI's 10.07%. David Dodd would confirm if the firm is quickly gaining an operational edge over the competitor.
233.16%
Net income/share CAGR above 1.5x ADI's 41.77% over 10 years. David Dodd would confirm if brand, IP, or scale secure this persistent advantage.
169.17%
5Y net income/share CAGR above 1.5x ADI's 99.05%. David Dodd would confirm if the firm’s strategy is more effective in generating mid-term profits.
36.82%
3Y net income/share CAGR 75-90% of ADI's 44.83%. Bill Ackman might push for an operational plan to match or beat the competitor’s short-term growth.
21.69%
Below 50% of ADI's 191.18%. Michael Burry would suspect poor capital allocation or persistent net losses eroding long-term equity build-up.
13.46%
Below 50% of ADI's 103.96%. Michael Burry sees a substantially weaker mid-term book value expansion strategy in place.
1.85%
Below 50% of ADI's 16.78%. Michael Burry suspects a serious short-term disadvantage in building book value.
677.64%
10Y dividend/share CAGR above 1.5x ADI's 182.23%. David Dodd checks if the firm's robust cash flows justify outpacing the competitor's increases.
167.94%
5Y dividend/share CAGR above 1.5x ADI's 54.95%. David Dodd checks if the firm's mid-term cash flows justify a faster dividend growth rate.
64.02%
3Y dividend/share CAGR above 1.5x ADI's 37.42%. David Dodd sees a superior short-term capital return strategy if supported by stable earnings.
12.02%
AR growth well above ADI's 12.13%. Michael Burry fears inflated revenue or higher default risk in the near future.
-3.32%
Inventory is declining while ADI stands at 1.71%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
1.49%
Positive asset growth while ADI is shrinking. John Neff sees potential for us to outgrow the competitor if returns are solid.
10.30%
BV/share growth above 1.5x ADI's 0.77%. David Dodd confirms if consistent profit retention or fewer write-downs yield faster equity creation.
-12.21%
We’re deleveraging while ADI stands at 0.03%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
-0.52%
Our R&D shrinks while ADI invests at 2.82%. Joel Greenblatt checks if we risk falling behind a competitor’s new product pipeline.
6.78%
SG&A growth well above ADI's 12.21%. Michael Burry sees potential margin erosion unless it translates into higher sales or brand equity.